Pazopanib as Third Line Therapy for Metastatic Renal Cell Carcinoma: Clinical Efficacy and Temporal Analysis of Cytokine Profile
Keywords: اینترلوکینها; kidney neoplasms; cytokines; pazopanib; biological markers; mortalityCFSE, carboxyfluorescein succinimidyl ester; CR, complete response; DOT2, therapy duration in second line setting; HGF, hepatocyte growth factor; IL, interleukin; mRCC, metastatic renal